These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5989008)

  • 1. [Metabolism and therapeutical effect of long-acting sulfonamide 4-sulfanilamido-5,6-dimethoxypyrimidine (Fanasil) in infants and children].
    Vest M
    Schweiz Med Wochenschr; 1966 Jul; 96(28):920-8. PubMed ID: 5989008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to adverse effects of sulfamethoxydine (2-sulfanilamido-5-methody-pyrimidine)].
    Strejchýr V; Capůrková V
    Cesk Pediatr; 1968 Oct; 23(10):926-8. PubMed ID: 5701265
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of a new preparation combining penicillin with triple sulfonamide.
    Nolan TC; Daniel WA
    J Med Assoc State Ala; 1966 May; 35(11):913-6. PubMed ID: 5326650
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with sulphormethoxine: a new long-acting sulphonamide.
    McGuinness BW
    Br J Clin Pract; 1969 Aug; 23(8):331-4. PubMed ID: 5801679
    [No Abstract]   [Full Text] [Related]  

  • 5. [A weekly dose of "long-acting" sulfonamide (4-sulfanilamido-5,6-dimethoxypyrimidine) in the treatment of urinary tract infections in the aged].
    Sourander L; Kasanen A
    Nord Med; 1965 Dec; 74(48):1229-30. PubMed ID: 5856947
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic studies with a long-acting sulfonamide in subjects of different ages. A modern approach to drug dosage problems in developmental pharmacology.
    Sereni F; Perletti L; Marubini E; Mars G
    Pediatr Res; 1968 Jan; 2(1):29-37. PubMed ID: 5636244
    [No Abstract]   [Full Text] [Related]  

  • 7. [A sulfanilamide with an extremely slow elimination. Elimination, distribution, dosage and enteric absorption of 4-sulfanilamido-5,6-dimethoxypyrimidine in children].
    Gladtke E
    Klin Wochenschr; 1965 Dec; 43(24):1332-4. PubMed ID: 5896035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum sulfonamide curve in children treated with a new sulfonamide-pyrazole compound in rectal administration].
    Rossolini A; Panero C; Puglisi P; Pindinelli C
    Minerva Pediatr; 1967 Oct; 19(40):1822-7. PubMed ID: 5606443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biliary excretion of the new long-acting sulfonamide Fanasil].
    Stauber R; Puxkandl H
    Wien Klin Wochenschr; 1966 Jan; 78(4):66-70. PubMed ID: 5962260
    [No Abstract]   [Full Text] [Related]  

  • 10. [The behavior of free sulfonamide levels in the blood and urine in children after oral administration of Madroxin-suspension "Polfa"].
    Szczepański Z
    Przegl Lek; 1969; 25(8):609-10. PubMed ID: 4897436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of the heparin and histamine indices in acute respiratory infection in children].
    Vereshchagin IA; Spalek SF
    Pediatr Akus Ginekol; 1973; 1():14-5. PubMed ID: 4705044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the posology of 2-sulfanylamido-3-methoxy-pyrazine (sulfamethopyrazine)].
    Di Nola F; Rapellini M; Pasquale A; Guasco C
    Minerva Med; 1966 Jun; 57(45):2059-67. PubMed ID: 5939218
    [No Abstract]   [Full Text] [Related]  

  • 13. [On anti-infective therapy and prevention in aged subjects by prolonged administration of minimal doses of 2-sulfanilamido-3-methoxypyrazine (sulfamethopyrazine)].
    Mars G; Santarato R; Necchi della Silva A
    Minerva Med; 1967 Mar; 58(18):697-700. PubMed ID: 6023813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doxycycline in current pediatrics. 45 cases of respiratory tract infection in newborn and young infants].
    Jacob A
    Maroc Med; 1971 Mar; 51(544):185-9. PubMed ID: 5562092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute respiratory infections of newborn infants with rondomycin].
    Korać D
    Srp Arh Celok Lek; 1967; 95(7):723-6. PubMed ID: 5599486
    [No Abstract]   [Full Text] [Related]  

  • 16. [The bile duct passability of the new long term sulfonamide fanasil after oral application].
    Stauber R
    Wien Klin Wochenschr; 1967 Apr; 79(15):269-73. PubMed ID: 5588954
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of acute respiratory infections in childhood with a new cephalosporin, ceftriaxone].
    Berni Canani M; Leone L; Della Rotonda G; Palazzi A
    Pediatr Med Chir; 1984; 6(2):277-80. PubMed ID: 6099551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma concentrations of 2-sulfanylamido-3-methoxy-pyrazine after a single administration in pediatrics].
    Marni E; Rizzoni G
    Minerva Pediatr; 1971 Dec; 23(48):2024-8. PubMed ID: 4950204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute lethal course of muco-cutaneo-ocular syndrome in a 35-year-old man after treatment with 2-sulfanilamido-6-methozypyrimidine (Sulfamethosydin)].
    Kastor O; Horácek J
    Dermatol Wochenschr; 1967 Dec; 153(48):1318-23. PubMed ID: 5600189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of urinary tract infections with a new sulfonamide in low dosage].
    Bergfors PG
    Lakartidningen; 1967 Mar; 64():Suppl 1:62-7. PubMed ID: 6042213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.